Search research articles
Contact Us
Filters
Showing results (351-360 of 384) with videos related to
Page
of 39
Sort By:
Bone Marrow Transplantation
|
November 21, 2021
A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients
Carlyn Rose Tan, Noel Estrada-Merly, Heather Landau, et al.
BMC Genomics
|
March 13, 2021
Whole genome comparisons reveal panmixia among fall armyworm (Spodoptera frugiperda) from diverse locations
Katrina A Schlum, Kurt Lamour, Caroline Placidi de Bortoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1
Rahul Banerjee, Matthew C Cheung, Benjamin Derman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline
Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Blood Neoplasia
|
April 20, 2026
Safety of MMR vaccination for patients with myeloma receiving daratumumab after autologous stem cell transplantation
James A Davis, Jessica McElwee, Rebecca Gonzalez, et al.
Current Molecular Pharmacology
|
May 14, 2015
Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels
Manu Ben-Johny, Ivy E Dick, Lingjie Sang, et al.
Transplantation and Cellular Therapy
|
July 3, 2025
Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT
Rahul Banerjee, Hermioni L Amonoo, Anna Barata, et al.
Transplantation and Cellular Therapy
|
November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation
Surbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
American Journal of Hematology
|
November 12, 2025
The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis
Matthew J Rees, Jack Khouri, Ariel F Grajales-Cruz, et al.
Blood Cancer Journal
|
April 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Doris K Hansen, Danai Dima, Hira Mian, et al.
Page
of 39
Search research articles
Search
Showing results (351-360 of 384) with videos related to
Sort By:
Page
of 39
Bone Marrow Transplantation
|
November 21, 2021
A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients
Carlyn Rose Tan, Noel Estrada-Merly, Heather Landau, et al.
BMC Genomics
|
March 13, 2021
Whole genome comparisons reveal panmixia among fall armyworm (Spodoptera frugiperda) from diverse locations
Katrina A Schlum, Kurt Lamour, Caroline Placidi de Bortoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1
Rahul Banerjee, Matthew C Cheung, Benjamin Derman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline
Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Blood Neoplasia
|
April 20, 2026
Safety of MMR vaccination for patients with myeloma receiving daratumumab after autologous stem cell transplantation
James A Davis, Jessica McElwee, Rebecca Gonzalez, et al.
Current Molecular Pharmacology
|
May 14, 2015
Towards a Unified Theory of Calmodulin Regulation (Calmodulation) of Voltage-Gated Calcium and Sodium Channels
Manu Ben-Johny, Ivy E Dick, Lingjie Sang, et al.
Transplantation and Cellular Therapy
|
July 3, 2025
Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT
Rahul Banerjee, Hermioni L Amonoo, Anna Barata, et al.
Transplantation and Cellular Therapy
|
November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation
Surbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
American Journal of Hematology
|
November 12, 2025
The Real-World Safety and Efficacy of Bispecific T-Cell Engager Therapy in Systemic AL Amyloidosis
Matthew J Rees, Jack Khouri, Ariel F Grajales-Cruz, et al.
Blood Cancer Journal
|
April 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Doris K Hansen, Danai Dima, Hira Mian, et al.
Page
of 39